Findings support clinical application of molecular imaging and use of novel immune cell targeting tracers for development of ...

The 2026 international intake at School of Management, Fudan University will take place from October 2025 to March2026. International applicants in all disciplines are welcomed to apply. The final ...

Confluent's latest Confluent Intelligence features include support for both Anthropic's Model Context Protocol (MCP) and the Agent2Agent (A2A) protocol within Streaming Agents, plus a new multivariate ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research ...

Confluent, Inc., the data streaming pioneer, is offering new Confluent Intelligence capabilities that connect artificial intelligence (AI) agents and uncover more accurate, intelligent data analysis.

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and ...

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four ...

Background Patients with heart failure (HF) frequently suffer from undetected declines in cardiorespiratory fitness (CRF), which significantly increases their risk of poor outcomes. However, current ...

Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...

Confluent’s Streaming Agents use the Agent2Agent (A2A) protocol to trigger and coordinate external AI agents using real-time data streams, making it easier to connect AI systems across an enterprise.

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.